Previous New Releases from NCBI BookshelfEpcoritamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments.Epcoritamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments.